 | Up a level |
Meier, FM; Frommer, KW; Dinser, R; Walker, UA; Czirjak, L; Denton, CP; Allanore, Y; Distler, O; Riemekasten, G; Valentini, G; Müller-Ladner, U; Matucci-Cerinic, M; Guiducci, S; Tyndall, A; Lapadula, G; Iannone, F; Becvar, R; Sierakowsky, S; Kowal-Bielecka, O; Cutolo, M; ... (2012). Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Annals of the rheumatic diseases, 71(8), pp. 1355-1360. London: BMJ Publishing Group 10.1136/annrheumdis-2011-200742
Mrowietz, U; Kragballe, K; Reich, K; Spuls, P; Griffiths, C E M; Nast, A; Franke, J; Antoniou, C; Arenberger, P; Balieva, F; Bylaite, M; Correia, O; Daudén, E; Gisondi, P; Iversen, L; Kemény, L; Lahfa, M; Nijsten, T; Rantanen, T; Reich, A; ... (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of dermatological research, 303(1), pp. 1-10. Berlin: Springer 10.1007/s00403-010-1080-1
